/Granules buying FDA-approved plants to speed U.S. push; Perrigo recalling infant suspension liquid;
NEWS

Granules buying FDA-approved plants to speed U.S. push; Perrigo recalling infant suspension liquid;

FiercePharma
2013/11/05

Granules India is to accelerate its expansion into the U.S. by acquiring Auctus Pharma and its FDA-approved plants. Article

Perrigo ($PRGO) is recalling 18 batches of its acetaminophen infant suspension liquid because some oral syringes may lack dose markings. Release

The Bangladeshi government has vowed to continue its crackdown on fake drugs, despite a backlash against its actions. Feature

Lehigh Valley Technologies is creating 52 jobs as it expands drug production in Pennsylvania. Piece

Repligen has completed a 9,000-square-foot expansion of its manufacturing facilities in Massachusetts. News (PDF)

A survey of mid-sized drugmakers found many think it will take up to 5 years to fully implement a serialization program. Article

Sanofi ($SNY) is planning to upgrade the vaccine plant it runs as a joint venture with the Thai government. Piece

Summary

> Granules India is to accelerate its expansion into the U.S. by acquiring Auctus Pharma and its FDA-approved plants. Article > Perrigo ($PRGO) is recalling 18 batches of its acetaminophen...